Lower Extremity Peripheral Arterial Disease: Its All About the Pulse. Spence M Taylor, M.D.

Similar documents
Chronic lower Extremity Peripheral Arterial Disease: The Relentless Pursuit of Mediocrity

Lower Extremity Peripheral Arterial Disease: Less is Sometimes More. Spence M Taylor, M.D.

LIMB SALVAGE IN THE DIABETIC PATIENT

Global Vascular Guideline on the Management of Chronic Limb Threatening Ischemia -a new foundation for evidence-based care

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE

Clasificación WIFI: Finalmente hablaremos el mismo idioma! WIfI: Wound, Ischemia, foot Infection The SVS Threatened Limb Classification

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

Acknowledgements. No tengo conflictos de interés que revelar. I have no conflicts of interest to disclose. Michael S. Conte. David G.

Endovascular Should Be Considered First Line Therapy

Imaging Strategy For Claudication

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

Current Vascular and Endovascular Management in Diabetic Vasculopathy

Interventional Treatment First for CLI

Making the difference with Live Image Guidance

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia

Peripheral arterial disease for primary care Ed Aboian, MD

Practical Point in Diabetic Foot Care 3-4 July 2017

Validation and Clinical Utility of the SVS WIfI Threatened Limb Classification

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia

Practical Point in Holistic Diabetic Foot Care 3 March 2016

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

3-year results of the OLIVE registry:

Pedal Bypass With Deep Venous Arterialization:

4/23/2009. Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes. Lower Extremity Revascularization Options: Key Factors to Consider

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

The SVS WIfI Classification: Does It Predict Amputation in Diabetic Patients?

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention

Surgical Options for revascularisation P E T E R S U B R A M A N I A M

Evidence-Based Optimal Treatment for SFA Disease

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome

SPINACH Making Limb Salvage Salad from Spinach alone

Peripheral Vascular Disease

EVALUATION OF THE VASCULAR STATUS OF DIABETIC WOUNDS Travis Littman, MD NorthWest Surgical Specialists

Disclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009

Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound

Will it heal? How to assess the probability of wound healing

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC

CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS

Angiosome concept myth or truth? Does it make a real difference in real world cases?

4/14/2016. How Far Should We Go with the Endovascular Treatment of Advanced PAD in the Era of Health Care Reform?

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014

Angiosome revascularization strategies in real world practice: how much difference does it make?

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease

BEST-CLI Trial Study Concept and Current Status

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can

Peripheral Arterial Disease: A Practical Approach

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Multidisciplinary approach to BTK Y. Gouëffic, MD, PhD

Do the newest grafts achieve comparable results to saphenous vein bypass? THE HEPARIN-BONDED eptfe GRAFT. C. Pratesi

Invasive treatment of chronic limb ischemia according to the Lower Extremity Grading System (LEGS) score: A 6-month report

Objective assessment of CLI patients Hemodynamic parameters

VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS

Current Status of Endovascular Therapies for Critical Limb Ischemia

Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization

Intercepting PAD. Playbook for Cardiovascular Care 2018 February 24, Jonathan D Woody, MD, FACS. University Surgical Vascular

Disclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium

Perfusion Assessment in Chronic Wounds

Olive registry: 3-years outcome of BTK intervention in Japan. Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan

Peripheral Arterial Disease: Who has it and what to do about it?

Ron Fairman, MD Vice-President of the Society for Vascular Surgery MedCAC 2015

FOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in

Fluorescent Angiography: Practical uses in the Clinical Setting

Vascular Surgery Cases: Detours. Brian F. Stull, RDMS, RVT UNC REX Healthcare Vascular Specialists

A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts. Avishai Meyer UCHSC resident, Surgery May 8, 2006

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines

Introduction. Risk factors of PVD 5/8/2017

Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage

Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data)

Distal By-Pass procedures can reduce limb loss

Clinical Approach to CLI and Related Diagnostics: What You Need to Know

PUT YOUR BEST FOOT FORWARD

Nurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge

Vascular screening in diabetic patients: how aggressive should we be and when to intervene?

The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study -

Disclosures. TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Purpose of Practice Guidelines

WHO YOU GONNA CALL? CLOT-BUSTERS!

Garland Green, MD Interventional Cardiologist. Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management

Transmetatarsal amputation in an at-risk diabetic population: a retrospective study

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI

Treatment Strategies For Patients with Peripheral Artery Disease

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

Due to Perimed s commitment to continuous improvement of our products, all specifications are subject to change without notice.

When and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu

Resident Teaching Conference 3/12/2010

Lower Extremity Revascularization D oes Anesthesia Matter. Onaona Gurney PGY 4

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan

Guidelines for Management of Peripheral Arterial Disease

Access strategy for chronic total occlusions (CTOs) is crucial

Transcription:

Lower Extremity Peripheral Arterial Disease: Its All About the Pulse Spence M Taylor, M.D. President, Greenville Health System Clinical University Senior Associate Dean for Academic Affairs and Diversity University of South Carolina School of Medicine Greenville April 28- May 1, 2016 G H S C l i n i c a l U n i v e r s i t y P a r t n e r s

Lower Extremity Peripheral Artery Disease Disclosure Statement World according to Spence Taylor Expert Opinion

Critical Limb Ischemia Management 2016 Case Presentation

Case Presentation 60yo diabetic presents w/ CLI Sent for A-gram

Case Presentation ABI from 0.3 to 0.8 (ankle pressure 90) Discharged home with f/u in clinic-one week With good blood flow, he will do well Comes to the ER at 10 days with a pulse and gas extending to the ankle

Lessons Learned Its All About the Pulse G H S C l i n i c a l U n i v e r s i t y P a r t n e r s

Wilford Hall USAF Medical Center Greenville Health System Greenville SC

Spence Taylor MD & the STS 1992

Factors associated with limb loss despite a patent infrainguinal bypass graft. Carsten CG, Taylor SM, Langan EM, Crane MM Am Surg. 1998 Jan;64(1):33-7 Lower-extremity limb salvage should parallel infrainguinal bypass graft patency. To determine factors associated with limb loss despite a patent bypass, we reviewed 191 consecutive infrainguinal bypasses in 158 patients followed prospectively over 42 months. In this series 191 of Bypasses/158 176 (92%) vein grafts, patients 15 (8%) expanded polytetrafluoroethylene grafts, 122 (64%) tibial artery bypasses, and 170 (89%) bypasses placed for limb salvage, 29 major lower-extremity (above-knee or below-knee) amputations were Mean performed f/u 42 in 29 months patients, 12 because of ischemia after graft thrombosis and 1729 (9% amputations of series) due to progression (17 [9% of soft total tissue series] infection/necrosis w/ patent despite bypass) a functioning bypass. Primary and secondary 36-month vein graft patencies by life-table analysis were 61 per cent and 81 per cent, respectively. When the 17 cases of limb loss were compared to the rest of the series, nonstatistically significant CKD, Diabetic neuropathic ulcers: independent predictors variables included male sex [11 (65%) vs 79 (56%); P = 0.608] and diabetes [12 (71%) vs 80 (57%); P = 0.310]. Statistically significant variables included black race [9 (53%) vs 39 (28%); P = 0.048]; chronic renal failure [6 (35%) vs 12 (9%); P = 0.005], placement to a tibial/pedal artery [15 (88%) vs 107 (62%); P = 0.034], distal anastomosis to the anterior tibial/dorsalis pedis (AT/DP) artery [8 (47%) vs 27 (16%); P = 0.004], and grafts requiring late revision [7 (41%) vs 22 (13%); P = 0.006]. Thirteen (76%) extremities had an intact pedal arch. Nine amputations were performed within 30 days (early group), and eight were performed from 45 days to 20 months

It s not about the pulse: More Cull DL, et al. Open versus Endovascular Intervention for Critical Limb Ischemia: A Population-Based Study. J Am Col Surg 2010;210(5):555-63

An Assessment Cull DL, et al: SSA 2009 Open Era 1996 n=570 30% Endo Era 2005 n=749 Open/ Endo 75%/25% 50%/50% 1) # of 2 revascularizations doubled (8%-19%) 2) Amputation rate not improved ~ 50% @ 3years

An Assessment Cull DL, et al: SSA 2009 Our shift from open surgery to endovascular, while less invasive, has increased the amount of care without improving outcomes It s not just about endovascular revascularization: There is more

Other Lessons Limb salvage is like cancer; complex, multifactorial (not just vascular), prognostically challenging and needs a multidisciplinary approach A standardized treatment approach is needed A standardized diagnostic terminology is needed Precision Medicine: Patient centered outcomes

If CLI is like cancer: Multidisciplinary treatment standardization..what is our appetite?

Our Observation & a Plan: Seems we get confused about how and when to treat people with PAD. Some perform open surgery for certain problems while others perform angioplasty. Some do nothing. Lets decide to put together a treatment algorithm to help direct how best to treat PAD given various clinical presentations. What do you think? Peter Mackrell MD 1999

Its 1999, why do we need to standardize and where is the confusion?

Type of Care Rendered? Toyota Corolla Care

Peripheral Angioplasty Less invasive Better tolerated Less durable Anatomy/Other: Short lesions Big diameter Good R/O Higher risk pts Open Bypass More invasive Less well tolerated More durable Anatomy/Other: Long lesions More ischemia Good risk pts Diabetics

The Lower Extremity Grading System (LEGS) Score Arteriographic Findings Presentation Functional Status Co-morbidities Technical Factors - Aortic - Claudication 5 - Ambulatory 0 - Obesity 2 All Cases < 3 cm aortic stenosis/ - Redo surgery 2 occlusion or 3-5 cm stenosis - Limb threatening - Ambulatory/ - High risk coronary of aorto-iliac bifurcation 8 ischemia 2 at home only 2 artery disease 3 - Redo angioplasty -2 > 3 cm aortic stenosis/ occlusion or > 5 cm stenosis - Non-ambulatory/ - Age Infrainguinal Cases of aorto-iliac bifurcation 0 transfer only 5 > 70 1 - Blind segment target 2 - Iliac - Non-ambulatory 20 > 80 2 TASC A or B 8 - No venous TASC C 2 conduit 6 TASC D 0 or - No vein w/ foot - Fem-pop-tib infection 8 < 5 cm occlusion/stenosis 5 > 5 cm occlusion w/ distal target 0 Isolated common/deep femoral stenosis 0 Possible score: 2-5 Possible score: 0-20 Possible score: 0-7 Possible score: -2-12 > 5 cm occlusion w/o distal target 6 Recommended Treatment: (sum of total score from each column) * If a heel ulcer and ESRD -0 9 = open surgery are present, double the score Possible score: 0-8 -10 19 = endovascular ->20 = primary amputation

Case Like Control a Lead Study Balloon 100pts LEGS v 100pts Contrary *LEGS better outcomes@ 6mos -Patency -Limb salvage -Ambulation We will figure it out as we learn more about endovascular

What more can we really learn? Twenty-Year Med Pub Search Endovascular intervention: 32,182 citations Open bypass: 5,369 citations Open bypass vs. Endovascular: 57citations We have looked at the elephant..from about every angle

The Oculostenotic Reflex

Multidisciplinary treatment standardization..we have a ways to go

Glimmers of hope Southern Arizona Limb Salvage Alliance (SALSA)

If PAD is like cancer: Standardized Terminology

The term CLI lacks specificity

Factors influencing amputation risk

The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI) Mills JL, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G on behalf the Society for Vascular Surgery Lower Extremity Guidelines Committee J Vasc Surg. 2014 Jan;59(1):220-34 29

WIfI Clinical Stage Ischemia - 0 Ischemia - 1 Ischemia - 2 Ischemia - 3 W-0 VL VL L M VL L M H L L M H L M M H W-1 VL VL L M VL L M H L M H H M M H H W-2 L L M H M M H H M H H H H H H H W-3 M M H H H H H H H H H H H H H H fi-0 fi-1 fi-2 fi-3 fi-0 fi-1 fi-2 fi-3 fi-0 fi-1 fi-2 fi-3 fi-0 fi-1 fi-2 fi-3 WIfI Clinical Stage Amputation Risk at 1 year 1 Very Low (3%) 2 Low (8%) 3 Moderate (25%) 4 High (50%)

SVS WIFI CLASSIFICATION GRADE WOUND ISCHEMIA FOOT INFECTION ULCER GANGRENE ABI TP INFECTION 0 None None >0.8 > 60 mm Hg None 1 Shallow None 0.6-0.79 40-59 mm Hg Mild 2 Deep Digits only 0.4-0.59 30-39 mm Hg Moderate 3 Extensive Extensive <0.39 < 30 mm Hg Severe (SIR) The WIfI classification system grades each factor on a severity scale from 0 to 3. The original document outlines each grade in much greater detail; the basic delineations for each factor are shown above with respect to unaffected, mild, moderate, and severe wound, ischemia, and foot infection grades.

Critical Limb Ischemia : Too Simple We need to devise a foot ischemia classification that takes into consideration the degree of foot wound Infection David L Cull M.D. 2007 32

Comparison of GCLI and WIfI Grades Greenville CLI Grades Wound Diameter Grade 1 3 Depth Grade 1 3 Type Ulcer/gangrene Location Grade 1 3 Ischemia Grade 1 3 Infection Grade 1-4 WIfI Grades Wound Grade 0 3 Ischemia Grade 0 3 Infection Grade 0-3

Prospective Analysis of Wound Characteristics, Degree of Ischemia, and Extent of Infection on Time to Wound Healing and Limb Salvage: An Early Validation of the SVS Lower Extremity Threatened Limb Classification System David L. Cull, MD Ginger Manos, MD Michael C. Hartley, MD Spence M. Taylor, MD Eugene M. Langan, MD John F. Eidt, MD Brent L. Johnson, MS G H S C l i n i c a l U n i v e r s i t y P a r t n e r s

Purpose To determine whether the WIfI clinical stage risk stratification estimated by the SVS expert panel compares to actual patient outcomes. To determine whether the WIfI clinical stage is predictive of wound healing.

Methods Jan 2008 Dec 2010 patients with a foot wound + revascularization procedure At the intervention the wound/infection grades were assigned by a vascular attending or resident Ischemia grade was assigned after the procedure

Results 139 patients/151 limbs/158 index wounds Males- 63% Mean age- 70 yrs Tobacco use- 66% Comorbidities Diabetes mellitus 65% Coronary artery disease 64% End stage renal disease 15%

139 patients/151 limbs/158 index wounds WIfI Clinical Stage Predicted Observed Observed Amputation Amputation Non-Healing Stage 1 (n= 40) 3% 3% 8% Stage 2 (n= 64) 8% 10% 19% Stage 3 (n= 46) 25% 23% 30% Stage 4 (n= 8) 50% 40% 63%

139 patients/151 limbs/158 index wounds Wound Healing OR Amputation OR (95% CI) (95% CI) WIfI Stage 1 1.00 (Referent) 1.00 (Referent) WIfI Stage 2.29 (0.08-1.08) 4.8 (0.6-40.5) WIfI Stage 3.15 (0.04-0.57) 10.8 (1.3-88.8) WIfI Stage 4.05 (0.01-0.31) 23.4 (2.0-270.2)

Factors Associated with Wound Healing Bivariate Analysis Smoking (p=0.03) Wound size (p=0.004) Wound depth (p=0.001) Ischemia grade (p<0.001) Factors Associated with Limb Amputation Bivariate Analysis Smoking (p=0.027) Wound size (p=0.026) Ischemia grade (p<0.001) Infection grade (p=0.05) Multivariate Analysis Ischemic grade Infection grade Multivariate Analysis Ischemia grade Infection grade Diabetes mellitus 40

Conclusions: WIfI promises not only to serve as a tool for comparing treatment modalities but also as a clinical decisionmaking tool to guide treatment

Risk of amputation versus SVS WIfI Stage: Compilation of published data Study (year): # limbs at risk Stage 1 Stage 2 Stage 3 Stage 4 Cull (2014): 151 37 (3%) 63 (10%) 43 (23%) 8 (40%) Zhan (2015): 201 39 (0%) 50 (0%) 53 (8%) 59 (37%) Darling (2015): 551 5 (0%) 111 (2%) 222 (6%) 213 (28%) Causey (2016): 160 21 (0%) 48 (25%) 42 (21%) 49 (31%) Beropoulis (2016): 126 29 (13%) 42 (19%) 29 (19%) 26 (38%) N = 1189 (weighted average) 131 (4% ) 314 ( 9%) 389 (11%) 355 (31%) Number of limbs at risk in each WIfI Stage with % amputation at 1 year in parentheses Averages in total in bottom row (in parentheses) are weighted

If PAD is like cancer: What about precision therapy targeted at each patient? Doctor Knows Best

Patient Centered Outcomes: What Does the Patient Want from Intervention? Analysis of 102 Patients; Elective Surgery 66% based decision on surgeon recommendation Success: No need to return to doctor -82% Maintenance of daily activity -65% Maintenance of mobility -61% Relief/avoidance pain -58% Continue hobbies -54% Continue work -12%

A Definition of Success Success after Revascularization for CLI According to the Patient All of the following: 1. Maintenance of living independence 2. Maintenance of ambulatory status 3. Control/relief of pain 4. No additional/non-routine physician visits 5. Survival for one year

Patient-Centered Outcome of Success Tested on 954 patients Successful Outcome 218/954 combining (23%) all components: Independent Predictors of Failure ESRD (OR 2.21; p=0.006) Impaired ambulation (OR 1.76; p=0.015)

A Resident s Observation: The residents, get confused about how and when to treat people with PAD. Some attendings perform open surgery for certain problems while others perform angioplasty. Some do nothing. We have decided to put together a treatment algorithm to help direct how best to treat PAD given various clinical presentations. What do you think? Taylor SM, et al. The LEGS Score: A proposed grading system to direct treatment of chronic lower extremity ischemia. Ann Surg; 2003: 812-819

Expert Opinion According to Spence Taylor It s not just about the pulse Vascular disease of the lower extremities is as deadly as cancer, why not stage it and treat it like cancer in a multidisciplinary fashion? Let s benchmark and standardize care like the oncologists; Should be easy Right? Maybe Doctor does not know best